Drug Trial Radar · NCT05905458
A Phase II Clinical Study of the Efficacy and Safety of HRS9950 Tablets in Chronic Hepatitis B Patients Who Are Virologically Suppressed on Nucleoside or Nucleotide Analogues (NAs)
Last checked: Nov 19, 2026Latest source record: Dec 3, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
54
Actual
Start
Jul 28, 2023
Primary completion
Nov 22, 2024
Study completion Nov 22, 2024
Sponsor
- Lead sponsor
- Chengdu Suncadia Medicine Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jun 15, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the efficacy and safety of HRS9950 tablets in chronic hepatitis B patients who are virologically suppressed on nucleoside or nucleotide analogues (NAs).
Conditions
- Chronic Hepatitis B
Interventions
HRS9950 tabletsDrug
HRS9950 tablets, oral, once a week, low dose
HRS9950 tabletsDrug
HRS9950 tablets, oral, once a week, high dose
HRS9950 placebo tabletsDrug
HRS9950 placebo tablets, oral, once a week.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in mean log10 serum hepatitis B surface antigen levels from baseline to week 24Time frame: Week 24
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Nanfang Hospital
Guangzhou, Guangdong, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.